Skip to main content
. 2015 Sep 25;21:2870–2876. doi: 10.12659/MSM.895603

Figure 3.

Figure 3

Correlation between PCDH17 methylation and 5-year overall survival in ccRCC patients. Patients with PCDH17 methylation showed significantly shorter 5-year overall survival than patients without (log-rank test, P < 0.0001).